Teladoc Health Inc. [NYSE: TDOC] loss -0.48% or -0.13 points to close at $27.07 with a heavy trading volume of 2977899 shares. The company report on January 23, 2023 that Teladoc Health Releases Annual Corporate Social Responsibility Report.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Industry leader details new commitments to drive health equity, reports 33% increase in employee volunteerism.
It opened the trading session at $26.40, the shares rose to $27.07 and dropped to $25.77, the range by which the price of stock traded the whole day. The daily chart for TDOC points out that the company has recorded -32.64% loss over the past six months. However, it is still -25.32% lower than its most recent low trading price.
If we look at the average trading volume of 4.62M shares, TDOC reached to a volume of 2977899 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Teladoc Health Inc. [TDOC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $32.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on October 24, 2022. While these analysts kept the previous recommendation, KeyBanc Capital Markets raised their target price to Sector Weight. The new note on the price target was released on September 16, 2022, representing the official price target for Teladoc Health Inc. stock. Previously, the target price had yet another raise to $35, while Truist analysts kept a Hold rating on TDOC stock.
The Average True Range (ATR) for Teladoc Health Inc. is set at 1.75, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 1.80. The Price to Book ratio for the last quarter was 0.72, with the Price to Cash per share for the same quarter was set at 5.83. Price to Free Cash Flow for TDOC in the course of the last twelve months was 21.54 with Quick ratio for the last quarter at 3.00.
Trading performance analysis for TDOC stock
Teladoc Health Inc. [TDOC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.69. With this latest performance, TDOC shares gained by 11.81% in over the last four-week period, additionally sinking by -32.64% over the last 6 months – not to mention a drop of -63.98% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 55.23, with the RSI for the last a single of trading hit 57.82, and the three-weeks RSI is set at 53.02 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 26.70, while it was recorded at 26.61 for the last single week of trading, and 33.12 for the last 200 days.
Teladoc Health Inc. [TDOC]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -11.76 and a Gross Margin at +57.96. Teladoc Health Inc.’s Net Margin is presently recorded at -21.09.
Return on Equity for this stock declined to -2.69, with Return on Assets sitting at -2.35.
Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.00 and a Current Ratio set at 3.10.
An analysis of insider ownership at Teladoc Health Inc. [TDOC]
There are presently around $3,655 million, or 83.80% of TDOC stock, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 18,928,440, which is approximately -9.252% of the company’s market cap and around 0.10% of the total institutional ownership; VANGUARD GROUP INC, holding 13,639,307 shares of the stock with an approximate value of $369.22 million in TDOC stocks shares; and BLACKROCK INC., currently with $315.5 million in TDOC stock with ownership of nearly 6.432% of the company’s market capitalization.
Positions in Teladoc Health Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 180 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 9,884,887 shares. Additionally, 284 investors decreased positions by around 13,959,130 shares, while 113 investors held positions by with 111,160,927 shares. The mentioned changes placed institutional holdings at 135,004,944 shares, according to the latest SEC report filing. TDOC stock had 43 new institutional investments in for a total of 900,862 shares, while 104 institutional investors sold positions of 3,183,272 shares during the same period.